Literature DB >> 29669679

Calcitonin Screening in Nodular Goiter-Upper Limits.

Friedhelm Raue, Karin Frank-Raue.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29669679      PMCID： PMC5938436          DOI： 10.3238/arztebl.2018.0221a

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN： 1866-0452            Impact factor:   5.594


× No keyword cloud information.
  4 in total

1.  Measurement of Basal Serum Calcitonin for the Diagnosis of Medullary Thyroid Cancer.

Authors:  Stephanie Allelein; Margret Ehlers; Corinna Morneau; Katharina Schwartz; Peter E Goretzki; Thomas Seppel; Joachim Feldkamp; Andreas Krieg; Wolfram Trudo Knoefel; Anne Kuebart; Matthias Haase; Till Dringenberg; Christine Schmid; Matthias Schott
Journal:  Horm Metab Res       Date:  2017-11-23       Impact factor: 2.936

2.  Refining calcium test for the diagnosis of medullary thyroid cancer: cutoffs, procedures, and safety.

Authors:  Caterina Mian; Michela Perrino; Carla Colombo; Elisabetta Cavedon; Gianmaria Pennelli; Stefano Ferrero; Simone De Leo; Cristiano Sarais; Chiara Cacciatore; Gloria Irene Manfredi; Uberta Verga; Maurizio Iacobone; Loredana De Pasquale; Maria Rosa Pelizzo; Leonardo Vicentini; Luca Persani; Laura Fugazzola
Journal:  J Clin Endocrinol Metab       Date:  2014-02-19       Impact factor: 5.958

3.  Usefulness of Serum Calcitonin in Patients Without a Suspicious History of Medullary Thyroid Carcinoma and with Thyroid Nodules Without an Indication for Fine-Needle Aspiration or with Benign Cytology.

Authors:  P W Rosario; M R Calsolari
Journal:  Horm Metab Res       Date:  2016-05-20       Impact factor: 2.936

Review 4.  Indications for the Surgical Management of Benign Goiter in Adults.

Authors:  Detlef K Bartsch; Markus Luster; Heinz J Buhr; Dietmar Lorenz; Christoph-Thomas Germer; Peter E Goretzki
Journal:  Dtsch Arztebl Int       Date:  2018-01-08       Impact factor: 5.594
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.